Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 8.24
-0.06 (-0.72%)
Oct 14, 2026, 2:24 PM CST
Cabio Biotech (Wuhan) Market Cap
Cabio Biotech (Wuhan) has a market cap or net worth of 1.39 billion as of October 13, 2026. It is the 20,565th most valuable company in the world and the 5,112th biggest in China. Its market cap has decreased by 68.40% in one year.
Market Cap
1.39B
Enterprise Value
1.22B
Revenue
313.99M
Global Rank
Country Rank
#5,112 China
PE Ratio
n/a
ChartMarket Cap Chart
Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 1.39B, a decrease of -75.00%. That is a compound annual growth rate of -18.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 1.39B | -64.33% |
| Dec 31, 2025 | 3.88B | 21.24% |
| Dec 31, 2024 | 3.20B | 6.31% |
| Dec 29, 2023 | 3.01B | -44.60% |
| Dec 30, 2022 | 5.44B | -26.24% |
| Dec 31, 2021 | 7.37B | 55.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Bioeasy Biotechnology | 2.69B |
| Guangdong VTR Bio-Tech | 2.65B |
| Shandong Sito Bio-technology | 2.57B |
| Suzhou Fushilai Pharmaceutical | 2.35B |
| Jilin Jian Yisheng Pharmaceutical | 2.32B |
| Jiangsu CoWin Biotech | 2.25B |
| Guiyang Xintian Pharmaceutical | 2.00B |
| Shanghai Hile Bio-Technology | 1.97B |